Skip to main content
. 2014 Jul 8;5(4):e01283-14. doi: 10.1128/mBio.01283-14

TABLE 1 .

Participant demographics and symptoms

Characteristic Value for group (na)b or statistic
UUI (60) Non-UUI Control (58) P valuec
Demographics
    Age (yrs) 63 (±12) 49 (±14) <0.05
    Race [no. (%)] 0.42
        Caucasian 50 (83) 41 (77)
        African-American 10 (17) 11 (21)
        Asian 0 (0) 1 (2)
    Estrogen status [no. (%)] <0.05
        Estrogen positive 16 (27) 31 (61)
        Estrogen negative 43 (73) 20 (39)
    Body mass index (kg/m2) 32 (±8) 28 (±6) 0.01
    Hypertension [no. (%)] 21 (35) 9 (17) 0.03
    Coronary artery disease [no. (%)] 9 (15) 1 (2) 0.02
Symptoms
    Symptom scored 66 (±23) 4 (±7) <0.05
    Health-related quality of life (HRQL)d 56 (±25) 99 (±3) <0.05
    Urinary Distress Inventory (UDI)e 102 (±47) 11 (±11) <0.05
    Pelvic Organ Prolapse Distress Inventory (POPDI)e 70 (±52) 28 (±32) <0.05
    Colorectal-Anal Distress Inventory (CRADI)e 71 (±61) 43 (±62) 0.02
a

n, no. of subjects.

b

Mean ± SD or no. (%).

c

Pearson’s chi-square and Fisher’s exact tests were used with categorical variables. Student’s t test was used with continuous variables.

d

Based on OAB questionnaire.

e

Based on Pelvic Floor Disease Inventory.